₹ 1445.5
Key Takeaways
Risk factor
Poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Fredun Pharmaceuticals Ltd. specializes in the development, manufacturing, and commercialization of a diverse range of products, including pharmaceuticals, nutraceuticals, and various herbal and dietary supplements for human consumption, alongside its animal healthcare portfolio. Nariman Bamansha Medhora established the company on June 8, 1987, and its main operations are conducted from Mumbai, India.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITD.
Data is available to registered users only